ALT
Altimmune Inc
2.90$
-3.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | |
| 5,079.6% | 5,108.1% | 2,140.0% | 1,220.0% | 740.0% | 660.0% | – | 600.0% | 299,200.0% | 100.0% | – | – | 48,490.3% | |
| -4,979.6% | 100.0% | -2,040.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -299,100.0% | 100.0% | – | – | -48,306.5% | |
| 5,079.6% | 45,700.0% | 429,740.0% | 423,100.0% | 396,060.0% | 395,620.0% | 316,540.0% | 344,720.0% | 299,200.0% | 70,803.8% | – | – | 219,977.4% | |
| 1,247.0% | 11,708.1% | 106,240.0% | 111,900.0% | 99,380.0% | 101,800.0% | 119,860.0% | 113,820.0% | 118,080.0% | 40,423.1% | – | – | 103,354.8% | |
| 1,247.0% | 90,973.0% | 533,840.0% | 535,000.0% | 495,440.0% | 497,420.0% | 436,400.0% | 458,540.0% | 118,080.0% | 111,226.9% | – | – | 275,074.2% | |
| -6,226.5% | -90,873.0% | -535,880.0% | -534,900.0% | -495,340.0% | -497,320.0% | -436,300.0% | -458,440.0% | -417,180.0% | -111,126.9% | – | – | -323,306.5% | |
| 8.0% | 5.4% | 20.0% | 20.0% | 120.0% | 20.0% | 20.0% | 5,280.0% | 9,900.0% | 3,369.2% | – | – | 11,406.5% | |
| -5,710.2% | -85,516.2% | -487,880.0% | -492,800.0% | -456,900.0% | -463,600.0% | -405,120.0% | -442,920.0% | -380,280.0% | -105,223.1% | – | – | -296,000.0% | |
| 152.5% | 4,989.7% | – | – | – | – | -13,620.0% | – | – | – | – | – | – | |
| -5,710.2% | -85,516.2% | -487,880.0% | -492,800.0% | -456,900.0% | -463,600.0% | -391,500.0% | -442,920.0% | -380,280.0% | -105,223.1% | – | – | -296,000.0% | |
| -5,668.8% | -80,402.7% | -485,720.0% | -491,560.0% | -456,040.0% | -462,920.0% | -404,520.0% | -437,040.0% | -369,840.0% | -101,753.8% | – | – | -298,787.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.